Advertisement
News
Subscribe to MDT Magazine News

Oconee Medical Center is Winner of Siemens 'Who Inspires You?' Video Contest

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

LAS VEGAS, March 15, 2011 /- Oconee Medical Center in Seneca, S.C., is the winner of Siemens "Who Inspires You?" video contest and the recipient of a new MAMMOMAT® Inspiration, Siemens next generation full-field digital mammography system. (Photo:...

TOPICS:

Repligen imaging agent meets goal in study review

March 15, 2011 4:45 am | by The Associated Press | Comments

Repligen Corp. said that its imaging agent RG1068 met its goals in a late stage clinical trial, as it allowed radiologists to accurately scan the pancreas of their patients without producing many more false positives.The results, disclosed Monday, come from a new analysis of the trial. Repligen...

510(k) Implementation: Discussion of an On-line Repository of Medical Device Labeling, and of Making Device Photographs Available in a Public Database Without Disclosing Propr...

March 15, 2011 4:37 am | by U.S. Food & Drug Administration | Comments

CDRH is exploring the development of a searchable medical device labeling repository that would be accessible by the public and provide useful product information to patients and health care practitioners. This might be similar to the labeling...

Advertisement

Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results

March 15, 2011 4:35 am | by Bio-Medicine.Org | Comments

SEATTLE, March 15, 2011 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth...

TOPICS:

Functional Technologies Awarded $2.5 Million from Government of Canada to Optimize Acrylamide-Preventing Yeast Technologies in Commercial Potato Processing

March 15, 2011 3:45 am | by The Associated Press | Comments

http://www.functionaltechcorp.com () —Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") is pleased to announce that its subsidiary, Phyterra Yeast Inc., has been awarded $2.5 million in non-dilutive funding from the Government of Canada's Atlantic Innovation Fund (AIF) under...

Argon Medical Devices Announces Exclusive License and Distribution Agreement for Optionâ„¢ Retrievable Inferior Vena Cava Filter

March 15, 2011 3:33 am | by Bio-Medicine.Org | Comments

ATHENS, Texas, March 15, 2011 /- Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP ("Rex Medical") for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an...

TOPICS:

BioDrain Medical, Inc. Retains CFSG1 as Its U.S. Investor Relations Firm

March 15, 2011 3:33 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, March 15, 2011 /- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ), producer of the FDA cleared Streamway™ System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 ("CFSG1") as its U.S. Investor Relations...

TOPICS:

OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical Inc. (OTC Bulletin Board: ONCSD ), a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. (NYSE Amex:...

TOPICS:
Advertisement

Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., March 15, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. (OTC Bulletin Board:...

TOPICS:

OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical, Inc. (OTC Bulletin Board: ONCSD ) announced today that Mr. Punit Dhillon, President and CEO, will present a company overview on Wednesday, March 16 at 2:00 pm PT at the ROTH 23rd Annual Growth Stock Conference being held at the Ritz-Carlton,...

TOPICS:

ARMSRx and 84 Lumber Hammer Down Rx Costs...Again

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

EIGHTY FOUR, Pa., March 15, 2011 /- ARMSRx Pharmacy Benefit Consulting, the nation's leading Pharmacy Benefit consulting firm, has consistently provided successful recommendations for their clients. On February 16th, ARMSRx presented results to one of their premier clients, 84 Lumber....

TOPICS:

AMSC to significantly expand wind business through proposed acquisition of power technologies company "The switch?

March 14, 2011 10:38 pm | by I-Micronews | Comments

American Superconductor Corporation (NASDAQ: AMSC), a global power technologies company, today announced that it has signed a definitive agreement to acquire The Switch Engineering Oy, a power technologies company headquartered in Finland.

Nursing home boom in China has little government involvement

March 14, 2011 9:39 pm | by EurekAlert | Comments

(Brown University) A new study of the growth and operation of nursing homes in Chinese cities finds that the industry, while still small, is surging to meet the country's overwhelming shift toward an older population. The almost entirely private-sector growth has far outpaced...

TOPICS:

U.S. FDA Approves Bayer's Gadavistâ„¢ (Gadobutrol) Injection for MRI of the Central Nervous System

March 14, 2011 9:36 pm | by Bio-Medicine.Org | Comments

WAYNE, N.J., March 14, 2011 /- Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist™ (gadobutrol) Injection, a macrocyclic gadolinium-based contrast agent (GBCA), for intravenous use in diagnostic magnetic resonance...

TOPICS:

Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading